Patent Assignment
Reel/Frame 049175/0901
Assignment of Assignor's Interest
Recorded: 2019-05-14
Pages: 10
Assignor
ALETHIA BIOTHERAPEUTICS INC.
Executed: 2017-06-15
Assignee
ADC THERAPEUTICS SA
BIOPOLE, ROUTE DE LA CORNICHE 3B, 1066 EPALINGES, SWITZERLAND
Covered Property
(1)
Antibodies That Specifically Block the Biological Activity of a Tumor Antigen
Application:
15/833,753 →
Publication:
US 2018/0369269
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 14, 2019
From: SULEA, TRAIAN
To: NATIONAL RESEARCH COUNCIL OF CANADA
Reel/Frame 049175/0874 →
Assignment of Assignor's Interest
May 14, 2019
From: TREMBLAY, BERNARD GILLES; FILION, MARIO
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 049175/0877 →
Assignment of Assignor's Interest
May 14, 2019
From: NATIONAL RESEARCH COUNCIL OF CANADA
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 049175/0898 →
Security Interest
May 19, 2020
From: ADC THERAPEUTICS SA
To: DEERFIELD PARTNERS, L.P., AS GRANTEE
Reel/Frame 052696/0247 →
Security Interest
Jun 30, 2020
From: ADC THERAPEUTICS SA
To: DEERFIELD PARTNERS, L.P.
Reel/Frame 053094/0602 →
Termination and Release of Patent Security Agreement
Aug 16, 2022
From: DEERFIELD PARTNERS, L.P.
To: ADC THERAPEUTICS SA
Reel/Frame 061200/0750 →